Since its discovery in England and France in 1986, vancomycin-resistant Enterococcus has
increasingly become a major nosocomial pathogen worldwide. Enterococci are prolific …

Urinary tract infections are more common, more severe, and carry worse outcomes in
patients with type 2 diabetes mellitus. They are also more often caused by resistant …

Bacterial and fungal co-infection has been reported in patients with COVID-19, but there is
limited experience on these infections in critically ill patients. The objective of this study was …

Background & Aims It remains unclear whether rectal colonization with multidrug-resistant
organisms (MDROs) is prevalent and predisposes to infections by the same pathogens in …

Background Quantification of acquisition routes of antibiotic resistant bacteria (ARB) is
pivotal for understanding transmission dynamics and designing cost-effective interventions …

The spread of multidrug-resistant organisms (MDRO) is associated with additional costs as
well as higher morbidity and mortality rates. Risk factors related to the spread of MDRO can …

Vancomycin-resistant enterococci (VRE) are relevant nosocomial pathogens with an
increasing incidence in the last decades. Their transmission is optimal in the hospital setting …

Background Vancomycin resistant enterococci (VRE) occur with enhanced frequency in
hospitalised patients. This study elucidates the prevalence of VRE on admission among …

Background Enterococcus spp. are particularly important etiological agents of nosocomial
infections. However, the clinical characteristics of and risk factors for enterococcal infections …

The emergence of multidrug-resistant enterococci (MDRE) and particularly vancomycin-
resistant enterococci (VRE) is considered a serious health problem worldwide, causing the …